title: BSR and BHPR rheumatoid arthritis guidelines on safety of anti-TNF therapies.
authors.affiliation: Rheumatology Department, Royal Derby Hospital, Derby, UK. tina.ding@doctors.net.uk
authors.forename: Tina
authors.initials: T
authors.lastname: Ding
authors.forename: Jo
authors.initials: J
authors.lastname: Ledingham
authors.forename: Raashid
authors.initials: R
authors.lastname: Luqmani
authors.forename: Sarah
authors.initials: S
authors.lastname: Westlake
authors.forename: Kimme
authors.initials: K
authors.lastname: Hyrich
authors.forename: Mark
authors.initials: M
authors.lastname: Lunt
authors.forename: Patrick
authors.initials: P
authors.lastname: Kiely
authors.forename: Marwan
authors.initials: M
authors.lastname: Bukhari
authors.forename: Rikki
authors.initials: R
authors.lastname: Abernethy
authors.forename: Ailsa
authors.initials: A
authors.lastname: Bosworth
authors.forename: Andrew
authors.initials: A
authors.lastname: Ostor
authors.forename: Kate
authors.initials: K
authors.lastname: Gadsby
authors.forename: Frank
authors.initials: F
authors.lastname: McKenna
authors.forename: Diana
authors.initials: D
authors.lastname: Finney
authors.forename: Josh
authors.initials: J
authors.lastname: Dixey
authors.forename: Chris
authors.initials: C
authors.lastname: Deighton
mesh_terms: D018501:Antirheumatic Agents / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D016903:Drug Monitoring / Q000379:methods; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D018579:Patient Selection; D017410:Practice Guidelines as Topic; D014409:Tumor Necrosis Factor-alpha / Q000009:adverse effects / Q000037:antagonists & inhibitors*; D006113:United Kingdom
chemical_list: D018501:Antirheumatic Agents; D007166:Immunosuppressive Agents; D014409:Tumor Necrosis Factor-alpha